Concepedia

R. Rao Koganty

RR

44

Publications

2.6K

Citations

26

H-Index

1973

Active since

Affiliations

University of Alberta(Current)

Memorial Sloan Kettering Cancer Center

University of Washington

R. Rao Koganty is an author at University of Alberta specializing in medicine, immunotherapy, and immunology.

Top concepts

Publications per year

1973–2007

44

Publications

44

GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.

Friedhelm Helling, Shengle Zhang, A Shang et al. · PubMed · 1995 · 207 citations

, , +19

Antibodies Against Mucin-Associated Sialyl-Tn Epitopes Correlate with Survival of Metastatic Adenocarcinoma Patients Undergoing Active Specific Immunotherapy with Synthetic STn Vaccine

Grant D. MacLean, Mark A. Reddish, R. Rao Koganty et al. · Journal of Immunotherapy · 1996 · 183 citations

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

Grant D. MacLean, Mark Reddish, R. Rao Koganty et al. · Cancer Immunology Immunotherapy · 1993 · 183 citations · Full text

, , +15

Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate.

P Y Fung, Marian Madej, R. Rao Koganty et al. · PubMed · 1990 · 162 citations

, , +16

Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide

Mark A. Reddish, Grant D. MacLean, R. Rao Koganty et al. · International Journal of Cancer · 1998 · 129 citations · Full text

, , +14

Rows per page

1–5 of 44